Ross Jeggo

Company: Servier

Job title: Global Head of Neuroscience & Immuno-Inflammation Therapeutic Aria

Seminars:

Exploring RNA Targeted Approaches for Rare Movement Disorders 1:02 pm

Exploring the medical landscape Investigating RNA-mediated approaches Outlining portfolio constructionRead more

day: Pre-Conference Discussion Day

Showcasing LRRK2 Inhibitors as Treatment for Parkinson’s Disease 12:00 pm

Exploring the role of LRRK2 in the pathophysiology of Parkinson’s disease Uncovering case studies which showcase the benefit of therapeutic approaches to inhibit LRRK2 Revealing how new small molecule inhibitors of LRRK2 can be used to treat Parkinson’s diseaseRead more